Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
UBS
Julphar
Accenture
Colorcon
McKesson
Chinese Patent Office
Medtronic
Dow

Generated: August 18, 2018

DrugPatentWatch Database Preview

Encore Dermat Company Profile

« Back to Dashboard

What is the competitive landscape for ENCORE DERMAT, and what generic alternatives to ENCORE DERMAT drugs are available?

ENCORE DERMAT has one approved drug.

There are two US patents protecting ENCORE DERMAT drugs.

There are twelve patent family members on ENCORE DERMAT drugs in nine countries.

Summary for Encore Dermat
International Patents:12
US Patents:2
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Encore Dermat

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Encore Dermat IMPOYZ clobetasol propionate CREAM;TOPICAL 209483-001 Nov 28, 2017 RX Yes Yes 9,855,334 ➤ Sign Up Y ➤ Sign Up
Encore Dermat IMPOYZ clobetasol propionate CREAM;TOPICAL 209483-001 Nov 28, 2017 RX Yes Yes ➤ Sign Up ➤ Sign Up
Encore Dermat IMPOYZ clobetasol propionate CREAM;TOPICAL 209483-001 Nov 28, 2017 RX Yes Yes 9,956,231 ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Non-Orange Book US Patents for Encore Dermat

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,877,974 Topical formulations comprising a steroid ➤ Sign Up
9,364,485 Topical formulations comprising a steroid ➤ Sign Up
9,439,911 Topical formulations comprising a steroid ➤ Sign Up
9,433,630 Topical formulations comprising a steroid ➤ Sign Up
9,655,907 Topical formulations comprising a steroid ➤ Sign Up
9,775,851 Topical formulations comprising a steroid ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Farmers Insurance
Healthtrust
Argus Health
Merck
Moodys
Federal Trade Commission
Chinese Patent Office
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.